137 related articles for article (PubMed ID: 29486295)
1. Parkinson's disease genetic risk in a midbrain neuronal cell line.
Pierce SE; Tyson T; Booms A; Prahl J; Coetzee GA
Neurobiol Dis; 2018 Jun; 114():53-64. PubMed ID: 29486295
[TBL] [Abstract][Full Text] [Related]
2. Enrichment of risk SNPs in regulatory regions implicate diverse tissues in Parkinson's disease etiology.
Coetzee SG; Pierce S; Brundin P; Brundin L; Hazelett DJ; Coetzee GA
Sci Rep; 2016 Jul; 6():30509. PubMed ID: 27461410
[TBL] [Abstract][Full Text] [Related]
3. Functional genomics elucidates regulatory mechanisms of Parkinson's disease-associated variants.
Chen R; Liu J; Li S; Li X; Huo Y; Yao YG; Xiao X; Li M; Luo XJ
BMC Med; 2022 Feb; 20(1):68. PubMed ID: 35168626
[TBL] [Abstract][Full Text] [Related]
4. Neuronal Differentiation of LUHMES Cells Induces Substantial Changes of the Proteome.
Tüshaus J; Kataka ES; Zaucha J; Frishman D; Müller SA; Lichtenthaler SF
Proteomics; 2021 Jan; 21(1):e2000174. PubMed ID: 32951307
[TBL] [Abstract][Full Text] [Related]
5. Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression.
Soldner F; Stelzer Y; Shivalila CS; Abraham BJ; Latourelle JC; Barrasa MI; Goldmann J; Myers RH; Young RA; Jaenisch R
Nature; 2016 May; 533(7601):95-9. PubMed ID: 27096366
[TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease candidate gene prioritization based on expression profile of midbrain dopaminergic neurons.
Vahedi S; Rajabian M; Misaghian A; Grbec D; Simon HH; Alavian KN
J Biomed Sci; 2010 Aug; 17(1):66. PubMed ID: 20716345
[TBL] [Abstract][Full Text] [Related]
7. Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1: a new genetic model for Parkinson's disease?
Le Pen G; Sonnier L; Hartmann A; Bizot JC; Trovero F; Krebs MO; Prochiantz A
Parkinsonism Relat Disord; 2008; 14 Suppl 2():S107-11. PubMed ID: 18585951
[TBL] [Abstract][Full Text] [Related]
8. Regional vulnerability of mesencephalic dopaminergic neurons prone to degenerate in Parkinson's disease: a post-mortem study in human control subjects.
Lu L; Neff F; Fischer DA; Henze C; Hirsch EC; Oertel WH; Schlegel J; Hartmann A
Neurobiol Dis; 2006 Aug; 23(2):409-21. PubMed ID: 16753304
[TBL] [Abstract][Full Text] [Related]
9. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of Lewy body-bearing neurons in Parkinson's disease.
Lu L; Neff F; Alvarez-Fischer D; Henze C; Xie Y; Oertel WH; Schlegel J; Hartmann A
Exp Neurol; 2005 Sep; 195(1):27-39. PubMed ID: 15944136
[TBL] [Abstract][Full Text] [Related]
11. Parkinson's disease-associated genetic variation is linked to quantitative expression of inflammatory genes.
Pierce S; Coetzee GA
PLoS One; 2017; 12(4):e0175882. PubMed ID: 28407015
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the mouse neural precursor line, SN4741, as a suitable proxy for midbrain dopaminergic neurons.
Boyd RJ; McClymont SA; Barrientos NB; Hook PW; Law WD; Rose RJ; Waite EL; Rathinavelu J; Avramopoulos D; McCallion AS
BMC Genomics; 2023 Jun; 24(1):306. PubMed ID: 37286935
[TBL] [Abstract][Full Text] [Related]
13. A Subpopulation of Dopaminergic Neurons Coexpresses Serotonin in Ventral Mesencephalic Cultures But Not After Intrastriatal Transplantation in a Rat Model of Parkinson's Disease.
Di Santo S; Seiler S; Ducray AD; Meyer M; Widmer HR
Cell Transplant; 2017 Apr; 26(4):679-691. PubMed ID: 27938488
[TBL] [Abstract][Full Text] [Related]
14. Multi-omics integration of scRNA-seq time series data predicts new intervention points for Parkinson's disease.
Mihajlović K; Ceddia G; Malod-Dognin N; Novak G; Kyriakis D; Skupin A; Pržulj N
Sci Rep; 2024 May; 14(1):10983. PubMed ID: 38744869
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Vulnerability of Insulator CTCF Motifs at Parkinson's Disease-Associated Genes in Response to Neurotoxicant Rotenone.
Freeman DM; Wang Z
Front Genet; 2020; 11():627. PubMed ID: 32774342
[TBL] [Abstract][Full Text] [Related]
16. The transcription factor PITX3 is associated with sporadic Parkinson's disease.
Fuchs J; Mueller JC; Lichtner P; Schulte C; Munz M; Berg D; Wüllner U; Illig T; Sharma M; Gasser T
Neurobiol Aging; 2009 May; 30(5):731-8. PubMed ID: 17905480
[TBL] [Abstract][Full Text] [Related]
17. Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson disease.
Dumitriu A; Golji J; Labadorf AT; Gao B; Beach TG; Myers RH; Longo KA; Latourelle JC
BMC Med Genomics; 2016 Jan; 9():5. PubMed ID: 26793951
[TBL] [Abstract][Full Text] [Related]
18. Molecular Features Underlying Neurodegeneration Identified through In Vitro Modeling of Genetically Diverse Parkinson's Disease Patients.
Lin L; Göke J; Cukuroglu E; Dranias MR; VanDongen AM; Stanton LW
Cell Rep; 2016 Jun; 15(11):2411-26. PubMed ID: 27264186
[TBL] [Abstract][Full Text] [Related]
19. MCF-7 as a Model for Functional Analysis of Breast Cancer Risk Variants.
Booms A; Coetzee GA; Pierce SE
Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1735-1745. PubMed ID: 31292138
[TBL] [Abstract][Full Text] [Related]
20. Vitamin C-Induced Epigenetic Modifications in Donor NSCs Establish Midbrain Marker Expressions Critical for Cell-Based Therapy in Parkinson's Disease.
Wulansari N; Kim EH; Sulistio YA; Rhee YH; Song JJ; Lee SH
Stem Cell Reports; 2017 Oct; 9(4):1192-1206. PubMed ID: 28943252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
